FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Not Serious About Mifepristone Review: GOP Senators

Politico says some GOP senators expressed frustration with FDA over a lack of apparent progress on its supposed safety review of the abortion drug mif...

latest-news-card-1
Medical Devices

Issues with AI-Enhanced Surgical Devices Cited

A detailed Reuters report looks at instances of surgical adverse events that may be related to artificial technology-enhanced medical devices being us...

latest-news-card-1
Medical Devices

FDA OKs Novocures Optune Pax for Advanced Pancreatic Cancer

FDA approves Novocures Optune Pax for use in combination with gemcitabine and nab-paclitaxel for adults with locally advanced pancreatic cancer.

latest-news-card-1
Biologics

Inhaled Gene Therapy for Lung Cancer Gets Expedited Status

FDA awards Krystal Biotech a Regenerative Medicine Advanced Therapy designation for KB707, an inhalable gene therapy being investigated for treating l...

latest-news-card-1
Human Drugs

Keytruda Regimen for PD-L1Positive Ovarian Cancers Approved

FDA approves Mercks Keytruda (pembrolizumab), as well as the fixed-dose combination pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex), in ...

latest-news-card-1
Biologics

FDA Tags Data Integrity, Inventory Lapses in AGC Biologics 483

FDA cites AGC Biologics for deficiencies in laboratory data controls and inventory management at its Bothell, WA, drug substance manufacturing site.

latest-news-card-1
Human Drugs

Biofrontera sNDA Seeks Expanded Ameluz Use

FDA accepts for review a Biofrontera supplemental NDA seeking to expand the label of its photodynamic therapy drug Ameluz (aminolevulinic acid hydroch...

latest-news-card-1
Human Drugs

Draft Guide on Medical Gases

FDA posts a draft guidance entitled Certification Process for Designated Medical Gases.

latest-news-card-1
Human Drugs

FDA Hits Tremfya TV Ad as False or Misleading

The CDER Office of Prescription Drug Promotion cautions Janssen Biotech about a direct-to-consumer TV ad for Tremfya that misleadingly overstates the ...

latest-news-card-1
Human Drugs

Rejection of Myopia Drug Raises Questions About Regulatory Consistency

A Washington Post opinion article takes issue with FDAs recent decision to reject a low-dose atropine treatment for pediatric myopia despite a large c...